MF:C14H233LN2O
MW:270.8
EINECS:200-803-8
Synonymes:2-DIETHYLAMINO-N-(2’6′-DIMETHYLPHENYL)ACETAMIDE HCL;2-DIETHYLAMINO-N-[2,6-DIMETHYLPHENYL]ACETAMIDE HCL;ALPHA-(DIETHYLAMINO)-2′,6′-ACETOXYLIDIDE HYDROCHLORIDE;A-(DIETHYLAMINO)-2 6-DIMETHYLACETANILIDE HYDROCHLORIDE;LIGNOCAINE HYDROCHLORIDE;LIDOCAINE HYDROCHLORIDE;LIDOCAINE HCL;2-(diéthylamino)-n-(2,6-diméthylphényl)-acetamidmonohydrochloride
| Nom du produit |
Chlorhydrate de lidocaïne |
| Autre nom |
2-(Diéthylamino)-N-(2,6-diméthylphényl) chlorhydrate d'acétamide |
| Essai (%) |
≥99,5 |
Odeur |
Caractéristiques |
| Couleur |
Poudre cristalline blanche |
CAS no. |
73-78-9 |
| Formule moléculaire |
C14H233LN2O |
Masse moléculaire |
270.7982 |
| Standard |
BP2007 / USP31 |
| Fonction |
Les fonctions principales sont les suivantes:
1.Anesthésie locale.
2. Traiter l'épilepsie.
3. Traiter l'asthme. |
| Applications |
Les applications principales sont les suivantes:
Appliqué dans des champs pharmaceutiques. |
| Emballage |
1kgor 5kg / sac, 25kg/fût |
| Durée de conservation |
24 mois |
| Espace de rangement |
Conserver dans des conteneurs scellés chez Cool & lieu sec. Protéger de la lumière, Humidité et infestation des ravageurs. |
| ÉLÉMENTS |
CARACTÉRISTIQUES |
RÉSULTATS |
| Apparence |
Poudre cristalline blanche |
Passe |
| Pureté |
99.00%-101.00% |
99.52% |
| Identification |
Chlorure |
Positif |
| Tester un |
Positif |
| Point de fusion |
74-79 degré |
76-78 degré |
| apparence de la solution |
Clair et incolore |
Passe |
| L'eau |
5.5-7.0% |
6.7% |
| Acidité PH |
4.0-5.5 |
5.2 |
| Cendres sulfatées |
0.10% max |
0.08% |
| Métaux lourds |
5ppm max |
Passe |
| 2, 6-Diméthylaniline |
100ppm max |
Passe |
|
Application
Lidocaine hydrochloride with a strong penetrating, diffuse strong, fast onset characteristics, anesthetic potency twice and procaine, and toxicity 1.5 minutes after anesthetic drugs, anesthesia for 1 à 1.5 heures. Can inhibit the absorption of central nervous system, and can suppress ventricular automaticity, shortened refractory period, the control room can be used as tachycardia, treating premature ventricular contractions, ventricular tachycardia and ventricular fibrillation and other arrhythmias symptoms. Disease of the heart itself or arrhythmias caused by cardiac glycosides are valid, the bad effects of supraventricular tachycardia. This product is the role of fast, short duration, oral invalid, often as an intravenous injection. As local anesthetics, lidocaine same mechanism of action, the role of strength, speed is also very similar to the onset, longer duration, faible toxicité, accumulation of small. Invasive surgery for a variety of clinical anesthesia, epidural, conduction anesthesia. A maximum amount of 60mg, anesthésie par infiltration avec 0.5% à 1% solution; 2%, 3% solution for nerve block and epidural anesthesia.
Ingrédient pharmaceutique actif (API), Anesthésie locale. Mainly used for clinical anesthesia, epidural anesthesia, anesthesia (including thoracoscopy or abdominal surgery for mucosal anesthesia) and nerve conduction block. Also be used for acute myocardial infarction and ventricular tachycardia premature ventricular contractions, can be used to digitalis toxicity, cardiac surgery and cardiac catheterization-induced ventricular arrhythmias. But arrhythmias are usually ineffective.
Directeur commercial